[慢性髓性白血病的二线治疗中的关键点]
1Department of Transfusion and Cell Therapy, Hamamatsu University School of Medicine.
概括
为慢性髓性白血病 (CML) 选择二线氨酸激酶抑制剂 (TKIs) 是复杂的. 本指南有助于根据耐药性或不耐受性选择最佳的TKI治疗,同时考虑患者的突变状态和TKI概况.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸激酶抑制剂 (TKIs) 已经改变了慢性髓性白血病 (CML) 的治疗方法.
- 像阿西米尼布这样的新药扩大了日本的一线治疗选择.
- 很大一部分患者由于耐药性或不耐受性需要二线治疗.
研究的目的:
- 为选择最佳的CML二线TKI治疗提供指导.
- 解决各种一线TKI选择所产生的复杂性.
- 审查管理二线TKIs的关键考虑因素,包括阿西米尼布和波纳替尼布.
主要方法:
- 对CML中二线TKI选择的当前临床指导方针和证据的审查.
- 分析影响治疗决策的因素,包括不良事件概况和突变状态.
- 在二线和后来的设置中评估TKI有效性和安全性数据.
主要成果:
- 切换到二线治疗需要仔细考虑停止治疗的原因 (不耐受性与耐药性).
- 不耐受性管理包括评估不良事件概况和潜在的交叉不耐受性.
- 耐药性需要BCR::ABL1突变评估,以指导对突变敏感的二线TKI的选择.
结论:
- 由于一线选项的增加,在CML中最优的二线TKI选择至关重要.
- 考虑突变概况和TKI特征的个性化治疗策略至关重要.
- 进一步的证据支持在以后的治疗线路中使用阿西米尼布和波纳提尼布.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K


